Latest news
Why uniQure (QURE) Is Up 6.4% After FDA Alignment On Accelerated AMT-130 Approval Path - simplywall.stsimplywall.st · Sun, 09 Aug 2026 19:35:10 GMTTonix Gets FDA Alignment on TNX-4800 Phase 2 Lyme Disease Study Design - The Clinical Trial VanguardThe Clinical Trial Vanguard · Wed, 05 Aug 2026 06:33:35 GMTTonix Pharmaceuticals Announces FDA Alignment on 3,300‑Participant Adaptive Phase 2 Lyme Study; TNX-4800 Dosing, 2027 Site Delivery - TradingViewTradingView · Mon, 03 Aug 2026 11:23:01 GMTTonix Pharmaceuticals Announces FDA Alignment on Phase 2 Study Design for TNX-4800 Lyme Disease Prevention Trial - Quiver QuantitativeQuiver Quantitative · Mon, 03 Aug 2026 11:15:00 GMTCalciMedica Announces FDA Alignment on Phase 2b Trial Design for Auxora in Acute Pancreatitis and Identifies Disease's First Potential Registrational Endpoints - PR NewswirePR Newswire · Wed, 29 Jul 2026 07:00:00 GMT